[13C6]-Clopidogrel Thiol Metabolite (mixture of diastereomers)

[13C6]-Clopidogrel Thiol Metabolite (mixture of diastereomers) is a stable isotope-labeled analog of clopidogrel thiol metabolite, a key intermediate in the metabolism of clopidogrel, a widely used antiplatelet medication. This compound is used primarily as a reference standard for quantification of clopidogrel thiol metabolite in biological matrices using mass spectrometry-based methods. Clopidogrel is a prodrug that is metabolized in the liver to its active form through a series of reactions, one of which involves the formation of clopidogrel thiol metabolite. This metabolite is responsible for the antiplatelet activity of clopidogrel, which is used to prevent blood clots in patients with cardiovascular diseases. Quantification of clopidogrel thiol metabolite in plasma or serum is important for assessing the effectiveness of clopidogrel therapy and for monitoring patient compliance. [13C6]-Clopidogrel Thiol Metabolite (mixture of diastereomers) is a mixture of six isotopically labeled analogs of clopidogrel thiol metabolite, each containing six 13C atoms. This compound is chemically stable and has the same physical and chemical properties as the unlabeled metabolite, making it an ideal internal standard for accurate and precise quantification of clopidogrel thiol metabolite in biological matrices. In summary, [13C6]-Clopidogrel Thiol Metabolite (mixture of diastereomers) is a valuable tool for researchers and clinicians involved in the development, validation, and implementation of mass spectrometry-based methods for quantification of clopidogrel thiol metabolite in biological matrices.